¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"second stage pain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • complex regional pain syndrome
    º¹ÇÕºÎÀ§ÅëÁõÁõÈıº
  • constant pain
    Áö¼ÓÅë
  • cramping pain
    °æ·ÃÅë
  • cutting pain
    Àý´ÜÅë
  • causalgic pain
    ÀÛ¿­Åë
  • central pain
    ÁßÃßÅëÁõ, ÁßÃ߽ŰæÅë
  • central pain syndrome
    ÁßÃßÅëÁõÁõÈıº
  • chest pain
    °¡½¿ÅëÁõ, ÈäÅë
  • cancer pain
    ¾ÏÅëÁõ
  • chronic pain syndrome
    ¸¸¼ºÅëÁõÁõÈıº
  • dull pain
    µÐÅë
  • delayed pain
    Áö¿¬ÅëÁõ
  • dental pain
    Ä¡Åë
  • deafferentation pain
    µé±æÂ÷´ÜÅëÁõ, ±¸½É·ÎÂ÷´ÜÅëÁõ
  • dragging pain
    °ßÀÎÅë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • stage-specific protein
    ¹ßÀ°´Ü°èƯÀ̴ܹéÁú
  • rapid ventricular filling stage
    ºü¸¥½É½ÇÃæ¸¸±â
  • reorganization stage
    À籸¼º½Ã±â
  • stage
    ±â, ½Ã±â
  • scar stage
    銁걉
  • secretory stage
    ºÐºñ±â
  • spasmodic stage
    ¿¬Ãà±â
  • sweating stage
    ¶¡³²±â
  • synaptene stage
    Á¢ÇÕ±â
  • terminal stage
    ¸»±â
  • trabecular stage
    ÀܱâµÕ±â
  • two stage sampling
    ÀÌ´ÜÇ¥º»ÃßÃâ¹ý
  • ulcer building stage
    ±Ë¾çÇü¼º±â
  • zygotene stage
    Á¢ÇÕ±â
  • abdominal pain
    º¹Åë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • postprandial pain
    ½ÄÈļº ÅëÁõ.
  • postprandial pain
    ½ÄÈļº ÅëÁõ(ãÝý­àõ ÷Ôñø)
  • posttraumatic pain
    ¿Ü»óÈÄ(µ¿)Åë(Áõ).
  • posttraumatic pain
    ¿Ü»óÈÄÅëÁõ(µ¿Åë)
  • precordial pain =precordialgia
    ¸íÄ¡µ¿Åë.
  • precordial pain =precordialgia
    ¸íÄ¡µ¿Åë(¡­ÔÙ÷Ô)
  • pressure pain
    ¾ÐÅë(äâ÷Ô).
  • pressure pain
    ¾ÐÅë(äâ÷Ô)
  • prick pain
    ÀÚÅë(ô§÷Ô).
  • prick pain
    ÀÚÅë(ô§÷Ô)
  • primary (pain) neuron
    ÀÏÂ÷(Åë)´º¿ì·Ð.
  • primary (pain) neuron
    ÀÏÂ÷(Åë)´º¿ì·Ð.
  • primary pain
    ¿ø¹ß¼º ÅëÁõ.
  • psychogenic pain
    ½ÉÀμº µ¿Åë
  • psychogenic pain disorder
    ½ÉÀμº µ¿ÅëÀå¾Ö(º´).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • union by second intention
    Á¦2À¯ÇÕ.
  • upper second molar
    »ó¾ÇÁ¦À̴뱸ġ(ß¾äÉð¯ì£ÓÞÏ¿öÍ).
  • upper second premolar
    »ó¾ÇÁ¦À̼ұ¸Ä¡(ß¾äÉð¯ì£á³Ï¿öÍ).
  • agonal stage
    »çÀü±â.
  • anal stage
    Ç×¹®±â(ùýڦѢ).
  • asphyxial stage
    Áú½Ä±â(òòãÓÑ¢).
  • babbling and lalling stage
    ÀçÀ߰Ÿ², ³²¾î±â(Õ½åÞÑ¢).
  • bell stage
    Á¾½Ã±â
  • bud stage
    ½Ï½Ã±â
  • cap stage
    °üÇü¼º±â.
  • cap stage
    ¸ðÀڽñâ
  • concrete operational stage
    ±¸Ã¼Àû Á¶À۴ܰè(Îýô÷îÜ ðÃíÂÓ«Í­)
  • conjunctional stage of the eyelid
    ´«²¨Ç®°áÇÕ±â
  • detachment stage
    Å»Âø´Ü°è(÷­ó·Ó«Í­)
  • developmental stage
    ¹ß´Þ´Ü°è(Û¡Ó¹Ó«Í­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CS IV clinical stage 4
ESLD end-stage liver disease
ESLF end-stage liver failure
ESRD end-stage renal disease
ESRF end-stage renal failure
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
FEV1 Forced Expired Volume in one second
FEV1.0 Forced expiratory volume in 1 second
SMN Second Malignant Neoplasm
SHG Second harmonic generation
SLO Second look operation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • terminal stage
    ¸»±â
  • tertiary stage
    »ï±â
  • third stage
    Á¦3±â
    žÆÀÇ ¸¸Ãâ ÈĺÎÅÍ ÅÂ¹Ý ¹× ³­¸·ÀÌ Àڱÿ¡¼­ ¸¸ÃâµÉ ¶§±îÁöÀÇ ½Ã±â.
  • two-stage prothrombin test
    ÀÌ ´Ü°è ÇÁ·ÎÆ®·Òºó ½ÃÇè
  • ugly duckling stage
    ¹Ì¿î ¿À¸® »õ³¢ ¹ßÀ° ´Ü°è, ¹Ì¿î ¿À¸® »õ³¢ÀÇ ½Ã±â, ¹Ì¿î ¿À¸® »õ³¢ ´Ü°è
  • wet stage
    ¹ßÇѱâ
  • XYZ-precision translation stage
    3Â÷¿ø Á¤¹Ð ÀüÀ§ ´Ü°è
  • zygotes stage
    Á¢ÇÕ±â
  • A delta pain fiber
    A µ¨Å¸ µ¿Åë ½Å°æ ¼¶À¯, A µ¨Å¸ ÅëÁõ ½Å°æ ¼¶À¯
  • a-delta pain fiber
    a-µ¨Å¸ ÅëÁõ ½Å°æ ¼¶À¯
    Á÷°æÀÌ 1-4§­ÀÎ ÅëÁõ Àü´Þ ½Å°æ ¼¶À¯ÀÌ´Ù. ¿¹¸®ÇÑ ÅëÁõÀ» Àü´ÞÇϸç, ¼ø°£ÀûÀÎ ÅëÁõÀ» ºü¸£°Ô Àü´ÞÇÑ´Ù.
  • abdominal pain
    º¹Åë
    º¹ºÎ ÂÊ¿¡¼­ ´À²¸Áö´Â ÅëÁõ, ºÒÆíÇÑ ´À³¦, ½ÉÇÑ °íÅë. ÁÖ·Î ¼ÒÈ­±â Áúȯ¿¡¼­ º¼ ¼ö ÀÖ´Â Áß¿äÇÑ Áõ»óÀ¸·Î¼­, ÀϹÝÀûÀ¸·Î ¾î´À °÷ÀÌ ¾ÆÇ°¡¿¡ µû¶ó Áø´ÜÀÌ °¡´ÉÇϹǷΠº¹ÅëÀÇ ºÎÀ§¸¦ Á¤È®È÷ ¾Ë¾Æ¾ß ÇÑ´Ù. ¶Ç ¾ÆÇÄÀÇ Á¤µµ¿Í ¾ÆÇ Çüŵµ Áø´ÜÀÇ ´Ü¼­°¡ µÈ´Ù. »ç¶÷¿¡ µû¶ó °¨¼ö¼ºÀÌ ´Ù¸¥µ¥, ÀϹÝÀûÀ¸·Î ½Å°æÁúÀûÀÎ »ç¶÷Àº ½ÉÇÏ°Ô ´À³¢´Â °æ¿ì°¡ ¸¹°í, ±× Áß¿¡´Â °úÀåÇØ¼­ Ç¥ÇöÇÏ´Â »ç¶÷µµ ÀÖ´Ù. ½ÉÇÑ º¹ÅëÀ» »êÅëÀ̶ó Çϸç, °£ÇæÀûÀ¸·Î ½Ã°£À» µÎ¾î µÇÇ®ÀÌÇÏ´Â °æ¿ì´Â ´ã¼®À̰ųª ½ÅÀå °á¼®À» ÀǽÉÇÒ ¼ö ÀÖ´Ù. ¸íÄ¡ ºÎ±ÙÀÌ °è¼Ó ¾ÆÇà ¶§´Â À§±Ë¾ç µîÀÇ Ãµ°øÀ̳ª º¹¸·¿° µîÀ» »ý°¢ÇÒ ¼ö ÀÖ´Ù. ¶§·Î´Â ±â»ýÃæ¿¡ ÀÇÇÑ °Í, È÷½ºÅ׸®¿¡ ÀÇÇÑ º¹ÅëÀÇ ¹ßÀÛµµ ÀÖ´Ù. ¶ÇÇÑ º¹Åë¿¡ µû¸£´Â ´Ù¸¥ Áõ»óµµ ÁÖÀÇÇÏ¿© Ä¡·á¸¦ ÇÏ¿©¾ß Çϸç, ½ÉÇÑ º¹Åë°ú ÇÔ²² ¹ß¿­À̳ª ±¸Å並 ¼ö¹ÝÇÒ ¶§´Â ±ÞÈ÷ ÀÇ»çÀÇ Áø´ÜÀ» ¹Þ¾Æ¾ß ÇÑ´Ù. ±¸Å䳪 ¼³»ç°¡ °è¼ÓµÇ´Â °æ¿ì´Â Å»¼ö »óÅ·ΠµÇ¾î ¼îÅ©¸¦ ÀÏÀ¸Å°´Â °æ¿ìµµ ÀÖÀ¸¹Ç·Î ÀÔ¿ø Ä¡·á¸¦ ÇÏ¿©¾ß ÇÑ´Ù. ÅëÁõÀÌ µÐÇϰí Áö¼ÓÀûÀ¸·Î µû²ûµû²ûÇÏ°Ô ¾ÆÇ º¹ÅëÀº º¯ºñ³ª Àå³»¿¡ °¡½º°¡ Â÷ ÀÖÀ» ¶§ º¼ ¼ö ÀÖÀ¸¸ç, ¿Â¾ö¹ýÀ» ¾²¸é ÄèÀûÇØÁø´Ù. ÀϹÝÀûÀ¸·Î ÁøÅëÁ¦³ª À§Àå ¾àÀ» º¹¿ëÇÏ´Â Á¤µµ´Â º° ÁöÀåÀÌ ¾øÁö¸¸, ÅëÁõÀÌ ½ÉÇÒ ¶§´Â Áï°¢ ÀÇ»çÀÇ Áø´ÜÀÌ ÇÊ¿äÇÏ¸ç ¼³»çÁ¦´Â ÀÇ»çÀÇ Áö½Ã¿¡ µû¶ó »ç¿ëÇÏ¿©¾ß ÇÑ´Ù. ¶ÇÇÑ ºÎÀ§º°·Î º¸¸é, ¸íÄ¡ ºÎ±ÙÀÇ °ÝÅëÀº À§Àå Áúȯ¿¡ ¸¹°í, ±Þ¼º À§¿°¡¤À§±Ë¾ç¡¤À§ ¾Ï¡¤À§ Çϼö ¿Ü¿¡ ½ÊÀÌÁöÀå ±Ë¾ç¡¤º¹¸·¿°¡¤´ã¼® ¹ßÀÛ¡¤±Þ¼º ÃéÀå¿°¡¤ÃéÀå ±«»ç µîÀ» ºñ·ÔÇÏ¿© ½É±Ù°æ»öÀÇ °æ¿ì¿¡µµ °¡²û º¼ ¼ö ÀÖ´Ù. ¿ìȾº¹ÀÇ ÅëÁõÀº ´ã¼®¡¤´ã³¶¿°À» ºñ·ÔÇÏ¿© °£À̳ª ½ÉÀåÀÇ º´ ¶Ç´Â È丷¿°À̳ª Æó·Å µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. ÁÂȾº¹ÀÇ °æ¿ì´Â ºñÀå
  • acute pain
    ±Þ¼º ÅëÁõ, ±Þ¼º µ¿Åë
    1. À¯¹ß ÀÎÀÚ³ª ¿øÀÎ ÀÎÀÚµéÀÌ Á¤»óÀ¸·Î µÇ´Âµ¥ ÇÊ¿äÇÑ ½Ã°£À̳ª Á¤»óÀûÀÎ Ä¡À¯ ±â°£ ³»¿¡ Á¦ÇÑµÇ¾î ³ªÅ¸³ª´Â ºÒÄèÇÑ °¨°¢. ÀüÅëÀûÀÎ Á¤ÀÇ¿¡ ÀÇÇϸé 6°³¿ù ¹Ì¸¸ÀÇ ±â°£ÀÌ´Ù. 2. ª°í ºñ±³Àû ½ÉÇÑ ÇüÅÂÀÇ µ¿Åë.
  • acute pathologic pain
    ±Þ¼º º´¸®Àû µ¿Åë
  • ascending pain pathway
    »óÇà µ¿Åë Àü´Þ·Î
  • atypical tooth pain
    ºñÁ¤Çü Ä¡Åë, ºñÁ¤Çü¼º Ä¡Åë
    µ¿ÀǾî=idio
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
second gas effect When a constant concentration of an anaesthetic like halothane is inspired, the increase in alveolar concentration is accelerated by concomitant administration of nitrous oxide, because alveolar uptake of the latter creates a potential subatmospheric intrapulmonary pressure that leads to increased tracheal inflow.
(05 Mar 2000)
second growth A second generation of timber of merchantable age.
(05 Dec 1998)
second heart sound The second sound heard on auscultation of the heart; signifies the beginning of diastole and is due to closure of the semilunar valves.
Synonym: second sound.
(05 Mar 2000)
second incisor Second maxillary or mandibular permanent or deciduous tooth on either side of the midsagittal plane of the head.
Synonym: lateral incisor.
(05 Mar 2000)
second law of thermodynamics <physics> All of the chemical and physical processes in a closed system tend to drive that system toward maximum entropy.
Clausius statement: No device can operate in a cycle and allow heat to transfer from a colder body to a hotter body unless other compensating activities are taking place.
Kelvin-Planck statement: no device can operate in a constant-temperature cycle and convert the heat it receives into work, unless other other compensating activities are taking place.
(09 Oct 1997)
second line chemotherapy <oncology> Chemotherapy given for a tumour which has already failed to respond to a first chemotherapy regimen (called first line).
(16 Dec 1997)
second-look operation Exploratory celiotomy within a year after apparently curative resection of intra-abdominal cancer, in patients with no sign or symptom of recurrence, to resect an occult tumour if present.
(05 Mar 2000)
second meiotic division The second of two consecutive divisions of the nucleus of an eukaryotic cell during the process of meiosis. It includes the following stages of meiosis: prophase II, metaphase II, anaphase II, and telophase II.
(09 Oct 1997)
second messenger <molecular biology> In many hormone sensitive systems the systemic hormone does not enter the target cell but binds to a receptor and indirectly affects the production of another molecule within the cell, this diffuses intracellularly to the target enzymes or intracellular receptor to produce the response. This intracellular mediator is called the second messenger.
Examples include cyclic AMP, cyclic GMP, IP3 and diacylglycerol.
(18 Nov 1997)
second messenger systems Systems in which an intracellular signal is generated in response to an intercellular primary messenger such as a hormone or neurotransmitter. They are intermediate signals in cellular processes such as metabolism, secretion, contraction, phototransduction, and cell growth. Examples of second messenger systems are the adenyl cyclase-cyclic AMP system, the phosphatidylinositol diphosphate-inositol triphosphate system, and the cyclic GMP system.
(12 Dec 1998)
second molar Seventh permanent or fifth deciduous tooth in the maxilla and mandible on either side of the midsagittal plane of the head following the arch form.
(05 Mar 2000)
second-order conditioning The use of a previously successfully conditioned stimulus as the unconditioned stimulus for further conditioning.
(05 Mar 2000)
second-order kinetics A term describing the reaction rate of a chemical reaction in which the rate is proportional to the product of the concentrations (in moles) of two of the reactants (also called bimolecular kinetics), or to the square of the molar concentration of the reactant if there is only one. Such a reaction might have an equation like rate = k[A][B] or rate = k[A]2, where k is the reaction rate constant, [A] is the concentration of reactant A, and [B] is the concentration of reactant B.
(09 Oct 1997)
second parallel pelvic plane The plane extending from the middle of the posterior surface of the pubic symphysis to the junction of the second and third sacral vertebrae, and laterally passing through the ischial bones over the middle of the acetabulum.
Synonym: second parallel pelvic plane, wide plane.
(05 Mar 2000)
second set rejection An accelerated rejection of a transplant that occurs when an individual has been previously sensitised to the graft.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á